-IFMAD has developed the reputation over many years of being the most interactive, stimulating and productive educational meeting in its field in Europe and since 2015 we are providing an even more comprehensive scientific and educational programme. In a friendly atmosphere difficult clinical challenges are dissected, discussed and reformulated with high ranking experts to achieve the best evidence based path to treatment in depression, anxiety and bipolar disorder. To avoid bias, our educational program is completely independent from pharmaceutical support. IFMAD will provide an opportunity to listen to leading experts who will provide up to date news on the most recent developments in Mood and Anxiety disorders.
-IFMAD 2019 topics will include: New findings on lithium, Nutritional psychiatry as it relates to mood disorders, Advances in treating bipolar depression and mixed states, Discussion on the on-line survey, Valproate in women of child bearing potential, Enduring effect of psychotherapy versus medication in anxiety disorders ,Hypochondriasis as an OCD disorder (ICD11)-Therapeutic implications, Personalized treatment of TRD, Esketamine in TRD-can esketamine snuff out suicidal thoughts, Advances in the treatment of TRD, Advances in technology and digital Psychiatry, Can we reopen blocked genetic pathways in TRD, New antipsychotics in the treatment of depression, Baclofen in anxiety disorders with alcohol dependence, Treatment of disorders of problematic use of internet, Inflammation in mood and anxiety disorders-Therapeutic implications.
The Organizer kindly offers possibility of the 15% discount of Registration Fee for the Conference as a part of our traditional mutual collaboration and promotion (reserved for active/regular members of the Psychiatric Association of Bosnia-Herzegovina)